Regulatory & Operations Guide

Compliant Sourcing: How It Works

US Med Access organizes case-specific sourcing research across provider credentials, package references, regulatory context, and route requirements. Every potential next step remains subject to independent review.

Step 01 Verify prescription, importer status, and sourcing fit
Step 02 Connect eligible buyers with licensed EU dispensing pharmacies
Step 03 Review route, handling, documentation, and destination requirements

The US Med Access Compliance Sourcing Loop

The workflow is designed to surface product, provider, documentation, route, and regulatory questions before a sourcing decision is considered.

01

Prescription Verification & Cost Audit

The US patient (or sponsoring health plan) submits a sourcing inquiry detailing the required medication. To initiate sourcing compliance, the patient must upload or provide details of a valid US prescription written by a licensed US physician.

We request current package and availability information from relevant dispensing providers and prepare a case-specific reference for further review.

Required Sourcing Documents:

Valid US licensed physician prescription
Patient passport page (customs declaration)
Personal-import documentation relevant to the case, if applicable
De-identified plan registration form (for B2B2C groups)

EU Dispensing Pharmacy Regulatory Standards:

German Federal Institute for Drugs (BfArM) registration
Dutch Health & Youth Care Inspectorate (IGJ) clearance
Route-relevant GDP and provider documentation review
Original manufacturing source verification check
02

Sourcing Facilitation & Connection

US Med Access facilitates the introduction between the US importer (patient or pharmacy provider) and the authorized European supplier. You act as the direct importer of record from the registered EU dispensing pharmacy.

Because we operate transparently, payments for the pharmaceutical ingredients are processed directly with the licensed European supplier. US Med Access charges a flat consultancy, shipping coordination, and compliance facilitation fee.

03

GDP Cold Chain Shipping & Customs Log

Specialty medications, especially biologics, are highly temperature-sensitive. The European provider packages medications under strict climate-controlled conditions (typically 2-8°C or ambient 15-25°C) inside validated passive thermal containers.

For temperature-sensitive products, a shipment plan may include qualified packaging and a temperature logger. Carrier selection, customs processing, and delivery timing depend on the specific product, route, and regulatory review; no customs or transit outcome is guaranteed.

Transit Tracking Controls:

Electronic continuous temperature loggers
Customs documentation review
Delivery verification report
Authorized EU pharmacist signature verification

Frequently Asked Questions

Get detailed information on compliance, logistics, cost savings structure, and legal boundaries.

FDA states that personal drug importation is generally illegal in most circumstances. In limited situations, FDA personnel may consider enforcement discretion case by case. A prescription, personal-use documentation, product details, and medical supervision may be relevant, but no shipment is guaranteed admissible. This is not legal or medical advice.

Temperature-sensitive products require a documented transport plan that matches the product and route. Packaging qualification, temperature monitoring, chain-of-custody records, and receipt checks should be evaluated for the specific product and shipment; logistics availability and performance vary by route.

US Med Access is a medical supply chain consultancy and facilitator. We are not a pharmacy and do not stock, compound, sell, or distribute medications. We coordinate availability and logistics discussions; any eligibility, regulatory, clinical, and import-admissibility decisions require independent review.

Quality and regulatory status must be assessed product by product. Manufacturer, batch, expiry, dispensing-pharmacy credentials, storage history, labeling, and destination-market requirements should be reviewed before a sourcing decision. No general equivalence determination is made on this site.

Timing varies by product availability, prescription review, supplier response, route, customs processing, and destination requirements. A sourcing inquiry can clarify estimated milestones, but no delivery date or import outcome is guaranteed.

Regulatory Information We Reference

This page is informational. Import requirements and product handling must be evaluated for the individual product, importer, route, and jurisdiction.

Regulatory Scope Notice

US Med Access operates as a consultancy facilitator. We do not participate in commercial distribution, retail pharmacy dispensing, compounding, or promotion of unapproved foreign drugs. Any potential sourcing request is subject to product-specific, clinical, legal, regulatory, and import-admissibility review. We do not source controlled substances.

Read the FDA personal importation guide  ·  Review the cold-chain control framework

Start Sourcing Inquiry